Pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015 as amended from time to time read with BSE circular No. LIST/COMP/01/2019-20 dated 2nd April, 2019, Medi-Caps has informed that the window for trading in the shares of the Company shall remain closed for all the Designated persons, Directors, KMP’s, Designated Employees, connected persons, Fiduciaries and their immediate relatives with effect from 1st January, 2024 for the purpose of consideration and approval of the Un-audited Standalone and Consolidated Financial Results for the quarter & nine month ended on 31st December, 2023. The Trading Window shall open 48 hours after the Un-audited Standalone and Consolidated Financial Results for the quarter and Nine Month ended on 31st December, 2023, become generally available. The date of meeting of the Board of Directors to consider the Standalone and Consolidated Un-audited Financial Results of the Company for the quarter and nine months ended on 31st December, 2023 shall be informed in due course. Further, it has submitted the above said information in XBRL mode (Excel Template provided by Exchange) along with the submission in PDF mode within prescribed time limit.
The above information is a part of company’s filings submitted to BSE.